encyclopedia of medical concepts
ψ 
ψ 
ψ 
ψ 
ψ 
ψ 

Smith-Lemli-Opitz Syndrome

More information in Books or onNLM PubMed
Definition: An autosomal recessive disorder of CHOLESTEROL metabolism. It is caused by a deficiency of 7-dehydrocholesterol reductase, the enzyme that converts 7-dehydrocholesterol to cholesterol, leading to an abnormally low plasma cholesterol. This syndrome is characterized by multiple CONGENITAL ABNORMALITIES, growth deficiency, and INTELLECTUAL DISABILITY.      Other names Syndrome, Lethal Acrodysgenital; Smith Lemli Opitz Syndrome, Type II; Smith Lemli Opitz Syndrome, Type I; Smith Lemli Opitz Syndrome, Type 2; Smith Lemli Opitz Syndrome; Reductase Deficiency, 7-Dehydrocholesterol; Reductase Deficiencies, 7-Dehydrocholesterol; RSH-SLO Syndromes; RSH SLO Syndrome; Lethal Acrodysgenital Syndromes; Deficiency, 7-Dehydrocholesterol Reductase; Deficiencies, 7-Dehydrocholesterol Reductase; Acrodysgenital Syndromes, Lethal; Acrodysgenital Syndrome, Lethal; 7-Dehydrocholesterol Reductase Deficiencies; 7 Dehydrocholesterol Reductase Deficiency; Smith-Lemli-Opitz Syndrome, Type II; Smith-Lemli-Opitz Syndrome, Type I; Smith-Lemli-Opitz Syndrome, Type 2; Smith-Lemli-Opitz Syndrome, Type 1

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012

Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy